Skip to main content
. 2010 Dec 6;3:247–254. doi: 10.2147/OTT.S15293

Figure 3.

Figure 3

Survivin-T34A has therapeutic potential, as it has been shown to induce apoptosis and immune modulation while reducing angiogenesis, metastasis, and cell cycle progression in survivin-expressing cells.